Hodgkin Lymphoma Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Hodgkin Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hodgkin Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hodgkin Lymphoma Treatment Overall Market Size
2.1 Global Hodgkin Lymphoma Treatment Market Size: 2022 VS 2035
2.2 Global Hodgkin Lymphoma Treatment Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hodgkin Lymphoma Treatment Players in Global Market
3.2 Top Global Hodgkin Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Hodgkin Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hodgkin Lymphoma Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hodgkin Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hodgkin Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hodgkin Lymphoma Treatment Market Size Markets, 2022 & 2035
4.1.2 Alocrest
4.1.3 ANK Program
4.1.4 Azacitidine
4.1.5 BMS-986016
4.1.6 BPX-501
4.1.7 Others
4.2 By Type - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Hodgkin Lymphoma Treatment Revenue, 2018-2023
4.2.2 By Type - Global Hodgkin Lymphoma Treatment Revenue, 2024-2035
4.2.3 By Type - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hodgkin Lymphoma Treatment Market Size, 2022 & 2035
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.2 By Application - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Hodgkin Lymphoma Treatment Revenue, 2018-2023
5.2.2 By Application - Global Hodgkin Lymphoma Treatment Revenue, 2024-2035
5.2.3 By Application - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Hodgkin Lymphoma Treatment Market Size, 2022 & 2035
6.2 By Region - Global Hodgkin Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Hodgkin Lymphoma Treatment Revenue, 2018-2023
6.2.2 By Region - Global Hodgkin Lymphoma Treatment Revenue, 2024-2035
6.2.3 By Region - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Hodgkin Lymphoma Treatment Revenue, 2018-2035
6.3.2 US Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.3.3 Canada Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.3.4 Mexico Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Hodgkin Lymphoma Treatment Revenue, 2018-2035
6.4.2 Germany Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.3 France Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.4 U.K. Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.5 Italy Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.6 Russia Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.7 Nordic Countries Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.4.8 Benelux Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Hodgkin Lymphoma Treatment Revenue, 2018-2035
6.5.2 China Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.5.3 Japan Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.5.4 South Korea Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.5.5 Southeast Asia Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.5.6 India Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Hodgkin Lymphoma Treatment Revenue, 2018-2035
6.6.2 Brazil Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.6.3 Argentina Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hodgkin Lymphoma Treatment Revenue, 2018-2035
6.7.2 Turkey Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.7.3 Israel Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.7.4 Saudi Arabia Hodgkin Lymphoma Treatment Market Size, 2018-2035
6.7.5 UAE Hodgkin Lymphoma Treatment Market Size, 2018-2035
7 Hodgkin Lymphoma Treatment Companies Profiles
7.1 Cell Medica Limited
7.1.1 Cell Medica Limited Company Summary
7.1.2 Cell Medica Limited Business Overview
7.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Major Product Offerings
7.1.4 Cell Medica Limited Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.1.5 Cell Medica Limited Key News & Latest Developments
7.2 Cellular Biomedicine Group, Inc.
7.2.1 Cellular Biomedicine Group, Inc. Company Summary
7.2.2 Cellular Biomedicine Group, Inc. Business Overview
7.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.2.4 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.2.5 Cellular Biomedicine Group, Inc. Key News & Latest Developments
7.3 Constellation Pharmaceuticals, Inc.
7.3.1 Constellation Pharmaceuticals, Inc. Company Summary
7.3.2 Constellation Pharmaceuticals, Inc. Business Overview
7.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.3.4 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.3.5 Constellation Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Curis, Inc.
7.4.1 Curis, Inc. Company Summary
7.4.2 Curis, Inc. Business Overview
7.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.4.4 Curis, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.4.5 Curis, Inc. Key News & Latest Developments
7.5 Faron Pharmaceuticals Oy
7.5.1 Faron Pharmaceuticals Oy Company Summary
7.5.2 Faron Pharmaceuticals Oy Business Overview
7.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Major Product Offerings
7.5.4 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.5.5 Faron Pharmaceuticals Oy Key News & Latest Developments
7.6 Fate Therapeutics, Inc.
7.6.1 Fate Therapeutics, Inc. Company Summary
7.6.2 Fate Therapeutics, Inc. Business Overview
7.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.6.4 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.6.5 Fate Therapeutics, Inc. Key News & Latest Developments
7.7 Gamida Cell Ltd.
7.7.1 Gamida Cell Ltd. Company Summary
7.7.2 Gamida Cell Ltd. Business Overview
7.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Major Product Offerings
7.7.4 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.7.5 Gamida Cell Ltd. Key News & Latest Developments
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Company Summary
7.8.2 Gilead Sciences, Inc. Business Overview
7.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.8.4 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences, Inc. Key News & Latest Developments
7.9 Incyte Corporation
7.9.1 Incyte Corporation Company Summary
7.9.2 Incyte Corporation Business Overview
7.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Major Product Offerings
7.9.4 Incyte Corporation Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.9.5 Incyte Corporation Key News & Latest Developments
7.10 Merck & Co., Inc.
7.10.1 Merck & Co., Inc. Company Summary
7.10.2 Merck & Co., Inc. Business Overview
7.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.10.4 Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.10.5 Merck & Co., Inc. Key News & Latest Developments
7.11 Mirati Therapeutics Inc.
7.11.1 Mirati Therapeutics Inc. Company Summary
7.11.2 Mirati Therapeutics Inc. Business Overview
7.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.11.4 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.11.5 Mirati Therapeutics Inc. Key News & Latest Developments
7.12 Molecular Templates Inc.
7.12.1 Molecular Templates Inc. Company Summary
7.12.2 Molecular Templates Inc. Business Overview
7.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.12.4 Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.12.5 Molecular Templates Inc. Key News & Latest Developments
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Company Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Major Product Offerings
7.13.4 NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue in Global Market (2018-2023)
7.13.5 NantKwest, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hodgkin Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Hodgkin Lymphoma Treatment Market Drivers in Global Market
Table 3. Hodgkin Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Hodgkin Lymphoma Treatment in Global Market
Table 5. Top Hodgkin Lymphoma Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hodgkin Lymphoma Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hodgkin Lymphoma Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hodgkin Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Hodgkin Lymphoma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hodgkin Lymphoma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Hodgkin Lymphoma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hodgkin Lymphoma Treatment Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Hodgkin Lymphoma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hodgkin Lymphoma Treatment Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Hodgkin Lymphoma Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hodgkin Lymphoma Treatment Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2024-2035
Table 30. Cell Medica Limited Company Summary
Table 31. Cell Medica Limited Hodgkin Lymphoma Treatment Product Offerings
Table 32. Cell Medica Limited Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Cell Medica Limited Key News & Latest Developments
Table 34. Cellular Biomedicine Group, Inc. Company Summary
Table 35. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 36. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Cellular Biomedicine Group, Inc. Key News & Latest Developments
Table 38. Constellation Pharmaceuticals, Inc. Company Summary
Table 39. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 40. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Constellation Pharmaceuticals, Inc. Key News & Latest Developments
Table 42. Curis, Inc. Company Summary
Table 43. Curis, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 44. Curis, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Curis, Inc. Key News & Latest Developments
Table 46. Faron Pharmaceuticals Oy Company Summary
Table 47. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product Offerings
Table 48. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Faron Pharmaceuticals Oy Key News & Latest Developments
Table 50. Fate Therapeutics, Inc. Company Summary
Table 51. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 52. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Fate Therapeutics, Inc. Key News & Latest Developments
Table 54. Gamida Cell Ltd. Company Summary
Table 55. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Product Offerings
Table 56. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Gamida Cell Ltd. Key News & Latest Developments
Table 58. Gilead Sciences, Inc. Company Summary
Table 59. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 60. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences, Inc. Key News & Latest Developments
Table 62. Incyte Corporation Company Summary
Table 63. Incyte Corporation Hodgkin Lymphoma Treatment Product Offerings
Table 64. Incyte Corporation Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Incyte Corporation Key News & Latest Developments
Table 66. Merck & Co., Inc. Company Summary
Table 67. Merck & Co., Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 68. Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Merck & Co., Inc. Key News & Latest Developments
Table 70. Mirati Therapeutics Inc. Company Summary
Table 71. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 72. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Mirati Therapeutics Inc. Key News & Latest Developments
Table 74. Molecular Templates Inc. Company Summary
Table 75. Molecular Templates Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 76. Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Molecular Templates Inc. Key News & Latest Developments
Table 78. NantKwest, Inc. Company Summary
Table 79. NantKwest, Inc. Hodgkin Lymphoma Treatment Product Offerings
Table 80. NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. NantKwest, Inc. Key News & Latest Developments
List of Figures
Figure 1. Hodgkin Lymphoma Treatment Segment by Type in 2022
Figure 2. Hodgkin Lymphoma Treatment Segment by Application in 2022
Figure 3. Global Hodgkin Lymphoma Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hodgkin Lymphoma Treatment Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Hodgkin Lymphoma Treatment Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hodgkin Lymphoma Treatment Revenue in 2022
Figure 8. By Type - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 9. By Application - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 10. By Type - Global Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 12. By Application - Global Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 14. By Region - Global Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 15. By Country - North America Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 16. US Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 20. Germany Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 21. France Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 28. China Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 32. India Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 34. Brazil Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Hodgkin Lymphoma Treatment Revenue Market Share, 2018-2035
Figure 37. Turkey Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Hodgkin Lymphoma Treatment Revenue, (US$, Mn), 2018-2035
Figure 41. Cell Medica Limited Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Curis, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Incyte Corporation Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck & Co., Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. NantKwest, Inc. Hodgkin Lymphoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
